CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Anika Therapeutics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Anika Therapeutics Inc
32 Wiggins Ave
Phone: (781) 457-9000p:781 457-9000 BEDFORD, MA  01730-2315  United States Ticker: ANIKANIK

Business Summary
Anika Therapeutics, Inc. is a joint preservation company focused on developing, manufacturing, and commercializing products based on hyaluronic acid (HA) technology platform. The OA Pain Management product family consists of Monovisc and Orthovisc that provides pain relief from osteoarthritis conditions and Cingal consisting of its cross-linked HA material combined with a fast-acting steroid. Its Joint Preservation and Restoration product family consists of its portfolio of orthopedic regenerative solutions products: Integrity, Tactoset, and Hyalofast; its line of sports medicine solutions repairs and reconstructs damaged ligaments and tendons, and its Arthrosurface portfolio of bone preserving joint technologies, including partial joint replacement, joint resurfacing, and minimally invasive and bone sparing implants. Its Non-Orthopedic product family provides orthopedic applications, including adhesion barrier product, advanced wound care products, and ear, nose and throat products.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202312/31/2023YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board Jeffery S.Thompson 57 9/1/2020 1/18/2011
President, Chief Executive Officer, Director Cheryl R.Blanchard 58 4/26/2020 8/31/2018
Chief Financial Officer, Executive Vice President, Treasurer Michael L.Levitz 49 8/10/2020 8/10/2020
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Parcus Medical, LLC 6423 Parkland Drive Sarasota FL United States
Arthrosurface, Inc. 28 Forge Parkway Franklin MA United States

Business Names
Business Name
ANIK
Anika Securities, Inc.
Anika Therapeutics Limited
4 additional Business Names available in full report.

General Information
Number of Employees: 357 (As of 12/31/2023)
Outstanding Shares: 14,660,000 (As of 12/31/2023)
Shareholders: 110
Stock Exchange: NASD
Federal Tax Id: 043145961
Fax Number: (781) 305-9720
Email Address: SMORAN@ANIKATHERAPEUTICS.COM


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024